Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 8:38 AM ET


Company Overview of Progen Pharmaceuticals, Inc.

Executive Profile

Thomas M. Aaberg Sr., M.D., FACS

Member of Scientific Advisory Board, Progen Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Dr. Thomas M. Aaberg,, Sr. M.D., FACS serves as Senior Professor of the Department of Ophthalmology of Emory University School of Medicine, Atlanta, Georgia. Dr. Aaberg came to Emory as the Chairman of Ophthalmology in 1988. Dr. Aaberg is internationally considered an expert on complicated retina detachment. He serves as a Member of Scientific Advisory Board of Progen Pharmaceuticals, Inc. He was Senior Associate Editor of the American Journal of Ophthalmology from 1982 ...

Corporate Headquarters

2479 East Bayshore Road
Palo Alto, California 94303

United States

Phone: 650-610-7800
Fax: 650-610-7801

Board Members Memberships

There is no Board Members Memberships data available.


Unknown/Other Education
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Progen Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at